Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVRNASDAQ:CVRXNASDAQ:LNSRNASDAQ:MODD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$4.38-10.1%$4.12$2.34▼$8.79$157.95MN/A204,643 shs279,964 shsCVRXCVRx$5.86-1.2%$6.57$4.30▼$18.55$152.79M1.3326,025 shs282,241 shsLNSRLENSAR$12.50$13.67$3.50▼$17.31$147.40M0.5282,408 shs57,825 shsMODDModular Medical$0.77-3.4%$0.91$0.68▼$2.65$41.77M0.22210,451 shs56,153 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global-10.06%-7.59%+6.83%-36.15%+437,999,900.00%CVRXCVRx-1.18%-10.67%+10.78%-48.78%-42.72%LNSRLENSAR0.00%-4.65%-11.85%-17.38%+156.15%MODDModular Medical-3.39%-8.77%-20.63%-14.35%-56.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AN/AN/AN/ACVRXCVRx3.0455 of 5 stars3.42.00.00.02.84.20.6LNSRLENSAR1.4019 of 5 stars2.03.00.00.02.82.50.0MODDModular Medical1.7851 of 5 stars0.04.00.00.03.83.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 3.00Buy$16.50276.71% UpsideCVRXCVRx 2.71Moderate Buy$14.50147.44% UpsideLNSRLENSAR 2.00Hold$15.0020.00% UpsideMODDModular Medical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MODD, CVRX, AVR, and LNSR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/9/2025CVRXCVRxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$20.00 ➝ $12.005/9/2025CVRXCVRxJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$15.00 ➝ $7.004/8/2025CVRXCVRxLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.00 ➝ $14.004/8/2025CVRXCVRxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$23.00 ➝ $18.003/24/2025LNSRLENSARBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/24/2025LNSRLENSARLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$16.00 ➝ $15.00(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$2.70M58.44N/AN/AN/A∞CVRXCVRx$52.87M2.89N/AN/A$2.73 per share2.15LNSRLENSAR$57.07M2.58N/AN/A$2.97 per share4.21MODDModular MedicalN/AN/AN/AN/A$0.25 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies GlobalN/AN/A0.00N/AN/AN/AN/AN/AN/ACVRXCVRx-$59.97M-$2.18N/AN/AN/A-116.91%-93.06%-51.78%8/4/2025 (Estimated)LNSRLENSAR-$14.38M-$4.85N/A∞N/A-34.03%-49.02%-21.12%8/6/2025 (Estimated)MODDModular Medical-$17.47M-$0.53N/A∞N/AN/A-197.97%-162.31%6/20/2025 (Estimated)Latest MODD, CVRX, AVR, and LNSR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025AVRAnteris Technologies GlobalN/A-$0.61N/A-$0.61N/AN/A5/8/2025Q1 2025CVRXCVRx-$0.56-$0.53+$0.03-$0.53$14.68 million$12.35 million5/8/2025Q1 2025LNSRLENSAR-$0.1550-$2.32-$2.1650-$2.32$13.40 million$11.53 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ACVRXCVRxN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/AMODDModular MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/AN/AN/ACVRXCVRx0.6912.0610.23LNSRLENSARN/A3.372.10MODDModular MedicalN/A5.305.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/ACVRXCVRx75.27%LNSRLENSAR40.15%MODDModular Medical27.47%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies GlobalN/ACVRXCVRx13.90%LNSRLENSAR38.52%MODDModular Medical20.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13836.06 millionN/AN/ACVRXCVRx16026.07 million21.12 millionOptionableLNSRLENSAR11011.79 million7.14 millionOptionableMODDModular Medical2054.25 million32.35 millionNot OptionableMODD, CVRX, AVR, and LNSR HeadlinesRecent News About These CompaniesModular Medical adds insulin delivery tech veteran to boardMay 29, 2025 | drugdeliverybusiness.comModular Medical, Inc.: Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of DirectorsMay 29, 2025 | finanznachrichten.deModular Medical Appoints Industry Veteran Jeff Goldberg to Board of DirectorsMay 28, 2025 | accessnewswire.comRegistration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025May 27, 2025 | accessnewswire.comModular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025May 22, 2025 | accessnewswire.comModular Medical files to sell 20.4M shares of common stock for holdersApril 26, 2025 | markets.businessinsider.comManchester Management Co Llc Acquires 156,250 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockMarch 25, 2025 | insidertrades.comModular Medical announces $12M private placementMarch 21, 2025 | drugdeliverybusiness.comModular Medical, Inc.: Modular Medical Announces $12 Million Private PlacementMarch 20, 2025 | finanznachrichten.deModular Medical Announces $12 Million Private PlacementMarch 20, 2025 | accessnewswire.comModular Medical takes step forward in CE mark process for insulin pump techFebruary 3, 2025 | drugdeliverybusiness.comModular Medical Announces BSI Group as Trusted Body for CE Mark ClearanceJanuary 30, 2025 | accessnewswire.comModular Medical, Inc.: Modular Medical Announces Licensing and Partnership Agreement With Nudge BGDecember 19, 2024 | finanznachrichten.deModular Medical Announces Licensing and Partnership Agreement With Nudge BGDecember 19, 2024 | accesswire.comManchester Management Co Llc Buys 21,000 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockDecember 5, 2024 | insidertrades.comModular Medical brings in $8.2MDecember 3, 2024 | drugdeliverybusiness.comModular Medical Announces Conference Call to Provide Business UpdateDecember 3, 2024 | finance.yahoo.comFavourable Signals For Modular Medical: Numerous Insiders Acquired StockDecember 2, 2024 | uk.finance.yahoo.comInsider Buying: Modular Medical, Inc. (NASDAQ:MODD) Director Buys 100,000 Shares of StockNovember 30, 2024 | insidertrades.comManchester Management Co Llc Purchases 166,666 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockNovember 26, 2024 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMODD, CVRX, AVR, and LNSR Company DescriptionsAnteris Technologies Global NASDAQ:AVR$4.38 -0.49 (-10.06%) As of 06/13/2025 04:00 PM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.CVRx NASDAQ:CVRX$5.86 -0.07 (-1.18%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$6.10 +0.24 (+4.03%) As of 06/13/2025 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.LENSAR NASDAQ:LNSR$12.50 0.00 (0.00%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$12.52 +0.02 (+0.16%) As of 06/13/2025 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.Modular Medical NASDAQ:MODD$0.77 -0.03 (-3.39%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$0.77 0.00 (0.00%) As of 06/13/2025 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
